CPIVC NEWS

China's NMPA grants IND clearance to Delonix Bioworks' DX-104 meningitis B vaccine candidate, paving way for Phase I trials

2026-06-01

Link: https://www.prnewswire.com/news-releases/delonix-bioworks-announces-ind-clearance-for-dx-104-a-novel-engineered-menb-omv-vaccine-candidate-in-china-and-australia-302681146.html